Indivior Pharmaceuticals Inc Net Income per Employee (INDV), current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket
 


Indivior Pharmaceuticals Inc   (NASDAQ: INDV)
 

Indivior Pharmaceuticals Inc Net Income per Employee

INDV's Quarterly Results, Trends, Rankings, Statistics
With an income increase of 226.19% in the third quarter 2026, year on year to cumulative value of $451 million, and with 1,000 employees, Indivior Pharmaceuticals Inc 's income per employee grew on trailing twelve month basis to $ 451,000. The income per employee at Indivior Pharmaceuticals Inc ' was above the company average.
The Healthcare sector has seen employees of 35 other companies achieving higher income per employee. While Indivior Pharmaceuticals Inc 's total ranking has deteriorated compared to the previous quarter from 502 to 508.


What is Income per Employee Ratio?






INDV Net Income per Employee (Sep 30 2026)
III. Quarter
(Jun 30 2026)
II. Quarter
(Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
Y / Y Net Income Change 226.19 % 577.78 % 89.36 % 390.48 % 90.91 %
Net Income per Employee (TTM) $ 451,000 356,000 252,000 210,000 128,000
INDV's Total Ranking # 508 # 502 # 437 # 288 #
Seq. Net Income Change 12.3 % 37.08 % -13.59 % 145.24 % 133.33 %


INDV Net Income per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 36
Healthcare Sector # 58
Overall Market # 508

Net Income per Employee Statistics
High Average Low
$ 356,000 $ 132,000 $ -7,000
(Jun 30 2026)   (Mar 31 2025)







Companies with similar Income per Employee for 12 month ending Sep 30 2026, within Healthcare Sector Income per Employee Income 12 month ending Sep 30 2026Number of Employees Sep 30 2026
Krystal Biotech Inc   763,281.36 $ 225.168  Million 295 
Illumina Inc   699,218.75 $ 895.000  Million 1,280 
Black Hawk Acquisition Corporation  649,852.50 $ 1.300  Million 2 
Eli Lilly And Company  551,594.00 $ 27,579.700  Million 50,000 
Indivior Pharmaceuticals Inc   451,000.00 $ 451.000  Million 1,000 
Denali Therapeutics Inc   393,667.99 $ 198.015  Million 503 
Neurocrine Biosciences Inc   351,250.00 $ 702.500  Million 2,000 
Standard Biotools Inc   342,097.69 $ 133.076  Million 389 
Regeneron Pharmaceuticals Inc   312,615.18 $ 4,817.400  Million 15,410 
Kiniksa Pharmaceuticals International Plc  299,366.12 $ 109.568  Million 366 
Bristol myers Squibb Company  284,338.46 $ 9,241.000  Million 32,500 


Date modified: 2026-10-30T13:13:54+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.